Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Dec;48(12):4580-5.
doi: 10.1128/JCM.01420-10. Epub 2010 Sep 29.

Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern

Affiliations

Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern

A Chakrabarti et al. J Clin Microbiol. 2010 Dec.

Abstract

Apophysomyces elegans is an emerging pathogen in India. We planned the present study to analyze the clinical pattern of the disease, to perform molecular strain typing, and to determine the in vitro activities of eight antifungal drugs against A. elegans. A total of 16 clinical and two environmental A. elegans isolates were included in the study. The clinical histories of the patients were noted. MICs or minimum effective concentrations (MECs) were determined for antifungal drugs by microdilution testing in accordance with CLSI standard M38-A2 guidelines. Of 16 patients, seven had rhino-cerebral, five had cutaneous, and three had renal zygomycosis. One patient had osteomyelitis. Uncontrolled diabetes was observed in 63% of the patients. Amplified fragment length polymorphism (AFLP) analysis divided the strains into two clearly different clades. The fingerprints of the environmental strains (including the type strain) were clearly different from those of the clinical strains. The MIC50s and MIC90s for amphotericin B, itraconazole, posaconazole, and isavuconazole were 2 and 4, 1 and 2, 0.5 and 1, and 2 and 4 μg/ml, respectively. The strains had high MICs for fluconazole, voriconazole, and echinocandins. The study indicates a possible change in the clinical pattern of zygomycosis due to A. elegans in India. The fungus caused not only cutaneous or subcutaneous infection but also other deep-seated infections, and the disease is commonly associated with uncontrolled diabetes. The AFLP patterns show a clear difference between environmental and clinical strains. Posaconazole is the most active drug against the isolates, followed by itraconazole. The MICs of amphotericin B against A. elegans were higher than those of the other drugs.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
AFLPs of 18 Apophysomyces isolates. Only bands in the range of 50 to 250 bp are shown. The scale bar indicates the percentages of similarity. Except for the CBS (Centraalbureau voor Schimmelcultures) numbers, all numbers next to the lanes correspond to the NCCPF (National Culture Collection of Pathogenic Fungi) collection.

References

    1. Alastruey-Izquierdo, A., M. V. Castelli, I. Cuesta, O. Zaragoza, A. Monzon, E. Mellado, and J. L. Rodriguez-Tudela. 2009. In vitro activity of antifungals against Zygomycetes. Clin. Microbiol. Infect. 15(Suppl. 5):71-76. - PubMed
    1. Almyroudis, N. G., D. A. Sutton, A. W. Fothergill, M. G. Rinaldi, and S. Kusne. 2007. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob. Agents Chemother. 51:2587-2590. - PMC - PubMed
    1. Alvarez, E., A. M. Stchigel, J. Cano, D. A. Sutton, A. W. Fothergill, J. Chander, V. Salas, M. G. Rinaldi, and J. Guarro. 2010. Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: proposal of three new species. Rev. Iberoam. Micol. 27:80-89. - PubMed
    1. Antachopoulos, C., J. Meletiadis, E. Roilides, T. Sein, and T. J. Walsh. 2006. Rapid susceptibility testing of medically important zygomycetes by XTT assay. J. Clin. Microbiol. 44:553-560. - PMC - PubMed
    1. Chakrabarti, A., S. S. Chatterjee, A. Das, N. Panda, M. R. Shivaprakash, A. Kaur, S. C. Varma, S. Singhi, A. Bhansali, and V. Sakhuja. 2009. Invasive zygomycosis in India: experience in a tertiary care hospital. Postgrad. Med. J. 85:573-581. - PubMed

Publication types

MeSH terms

Substances